| Date | Title | Description | Source |
| 03.04.2024 | SoftBank's View files for bankruptcy 3 years after its SPAC.... | Premium Finance SoftBank's View files for bankruptcy 3 years after its SPAC. Here's how it went from... | businessin... |
| 13.03.2024 | Prognos Health and Invitae Partner to Improve Diagnosis and ... | Prognos Health, the most-trusted provider of real-world data, and Invitae, a leading medical genetic... | einpresswi... |
| 23.01.2024 | Invitae Sells Reproductive Health Assets to Natera for Up to... | What You Should Know:
– Invitae (NYSE: NVTA), a medical genetics company, announced the completion o... | hitconsult... |
| 15.03.2023 | Invitae to Present Data at The American Clinical Genetics Me... | – New research looking at underrepresented racial, ethnic and ancestry groups underscores the import... | einpresswi... |
| 28.02.2023 | Invitae Reports Fourth Quarter and Full Year 2022 Financial ... | – Entered into a ~$336 million transaction for the 2024 convertible notes, effectively addressing ~9... | einpresswi... |
| 01.08.2022 | Slone Partners Places Thomas Schlumpberger as Chief Executiv... | “Thomas Schlumpberger is an experienced and admired leader in the POC diagnostics field where he has... | prweb.com/... |
| 01.08.2022 | Eight Business Leaders Share Their Takes On Unhelpful Produc... | There’s a lot of great business advice out there—but there’s also an equal amount of unhelpful advic... | forbes.com... |
| 16.06.2022 | Eight Steps A Leader Should Take When Faced With A Company C... | There are many crises that a company can face during its lifetime, and they happen for many differen... | forbes.com... |
| 08.06.2022 | Employees Quitting Due To Bad Leadership? Nine Ways To Fix I... | As the Great Resignation continues, one in five employees say they are planning to switch jobs in th... | forbes.com... |
| 30.03.2022 | Invitae Launches Genomics-Forward Digital Health Platform | What You Should Know:
– Invitae launches a seamless digital platform to enhance patient and provider... | hitconsult... |
| 07.03.2022 | KCNT1 Epilepsy Foundation Launches Digital Natural History S... | CONTOOCOOK, N.H. (PRWEB) March 07, 2022
The KCNT1 Epilepsy Foundation today announced in partnership... | prweb.com/... |
| 10.01.2022 | Invitae Reports Preliminary 2021 Revenue of More Than $458 M... | SAN FRANCISCO, Jan. 10, 2022 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical gen... | marketscre... |
| 09.11.2021 | Invitae Reports $114.4 Million In Revenue Driven By 296,000 ... | — Q3 2021 revenue increases more than 66% on volume growth of 89% from Q3 2020 — — Full-year 2021 re... | aithority.... |
| 09.11.2021 | Invitae Reports $114.4 Million in Revenue Driven by 296,000 ... | SAN FRANCISCO, Nov. 8, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company... | marketscre... |
| 22.10.2021 | Invitae : UCL and the Francis Crick Institute Announce New D... | SAN FRANCISCO, Oct. 22, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), University College London (UCL), ... | marketscre... |
| 07.09.2021 |
Wavemaker Three-Sixty Health Gets Exit At Ciitizen
| Los Angeles-based healthcare venture capital investor Wavemaker Three-Sixty Health has scored an exi... | socaltech.... |
| 07.09.2021 | Invitae : to Acquire Ciitizen to Strengthen its Patient-Cons... | SAN FRANCISCO, Sept. 7, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics compan... | marketscre... |
| 07.09.2021 | Genetic testing company Invitae snaps up digital health reco... | Photo: FatCamera/Getty Images | mobihealth... |
| 07.09.2021 | Invitae to Acquire Ciitizen to Strengthen its Patient-Consen... | | prnewswire... |
| 09.07.2021 | Invitae Acquires Ciitizen for $325M to Strengthen its Patien... | What You Should Know:
– Medical genetics company Invitae today announced its $325M acquisition of Ci... | hitconsult... |
| 17.06.2021 | How companies like 23andMe and Helix are forging the future ... | 23andMe cofounder Anne Wojcicki. Kimberly White / Getty Images This story is available exclusively t... | businessin... |
| 11.06.2021 | Invitae appoints technology and medtech veteran Roxi Wen as ... | | prnewswire... |
| 11.06.2021 | INVITAE CORPORATION
Invitae : appoints technology and medte... | SAN FRANCISCO, June 11, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics compan... | marketscre... |
| 14.05.2021 | Prevent Blindness Declares Second Annual Inherited Retinal D... | Prevent Blindness declares May 16-22, 2021, as it's second annual “Inherited Retinal Disease (IRD) G... | prweb.com/... |
| 15.04.2021 | Study finds risk-causing genetic changes in nearly 1 in 6 pa... | | prnewswire... |
| 06.04.2021 | Invitae surges after report says Softbank will lead a $1.2 b... | The genetic testing company Invitae is set to receive a $1.2 billion investment led by Softbank.
Inv... | businessin... |
| 05.04.2021 | INVITAE CORPORATION
Invitae : to acquire Genosity to accele... | SAN FRANCISCO, April 5, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics compan... | marketscre... |
| 05.04.2021 | Invitae Announces $1.15 Billion Investment Supporting Ongoin... | | prnewswire... |
| 05.04.2021 | Invitae to acquire Genosity to accelerate access to personal... | | prnewswire... |
| 05.04.2021 | INVITAE CORPORATION
Invitae : Announces $1.15 Billion Inves... | SAN FRANCISCO, April 5, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics compan... | marketscre... |
| 11.03.2021 | Invitae Releases Inaugural Environmental, Social and Governa... | SAN FRANCISCO, March 11, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical ge... | oaoa.com/n... |
| 23.02.2021 | Invitae expands capabilities of its advanced clinical chatbo... | | prnewswire... |
| 23.02.2021 | Invitae expands capabilities of its advanced clinical chatbo... | SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical gen... | oaoa.com/n... |
| 10.02.2021 | Gene screenings hold disease clues, but unexplained anomalie... | Tran knew she had an elevated risk of developing breast cancer because of her family history — her m... | medcitynew... |
| 21.01.2021 | Invitae Announces Pricing of Public Offering of Common Stock | | prnewswire... |
| 20.01.2021 | Invitae Announces Proposed Public Offering of Common Stock | | prnewswire... |
| 17.12.2020 | Invitae Introduces Routine Exome Reanalysis to Help Patients... | | prnewswire... |
| 19.11.2020 | New Study Highlights the Importance of Genetic Testing for P... | | prnewswire... |
| 08.10.2020 | New Study Finds Germline Genetic Testing Detects Actionable ... | | prnewswire... |
| 08.10.2020 | Invitae : New Study Finds Germline Genetic Testing Detects A... | SAN FRANCISCO, Oct. 8, 2020 /PRNewswire/ -- Tumor-only genetic sequencing misses medically actionabl... | marketscre... |
| 05.10.2020 | Invitae closes $1.4B acquisition of Boulder’s ArcherDX | Genetics tester Invitae Corp. (NYSE: NVTA) closed on its $1.4 billion acquisition of ArcherDX Inc., ... | dailycamer... |
| 05.08.2020 | INVITAE CORPORATION
Invitae : Reports $46.2 Million in Reve... | SAN FRANCISCO, Aug. 4, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical gene... | marketscre... |
| 06.12.2019 | Analysis: November 2019 Health IT M&A Activity, Public C... | – Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M... | hitconsult... |
| 07.11.2019 | Vermont Health Network Launches Pilot Project to Offer Free ... | Key Highlights
LunaPBC announces a partnership allowing patients in Vermont to donate genetic inform... | hitconsult... |
| 20.06.2019 | Invitae Acquires Singular Bio, for $55M | Invitae Corporation (NASDAQ: NVTA), a San Francisco, CA-based medical genetics company, is to acquir... | finsmes.co... |
| 28.09.2017 | Charting the growth in the reproductive health genetic testi... | But now there has been progress in different methods of reproductive genetic testing. For instance, ... | medcitynew... |
| 31.07.2017 | Safeguard Scientifics Partner Company Good Start Genetics To... | Safeguard Scientifics, Inc. (NYSE:SFE) today announced that its partner company, Good Start Genetics... | citybizlis... |
| 26.07.2017 | The second coming of consumer genomics with 3 predictions fo... | A brief history of human genomics
Genomics is defined by the WHO as the study of all parts of an org... | medcitynew... |
| 25.05.2017 | Can telehealth solve America’s genetic counselor shortage? | The trouble is, there aren’t that many trained genetic counselors out there. Lisa Alderson, cofounde... | medcitynew... |
| 28.10.2016 | Digital health deals: Vocera buys Extension, Red Cross-Telad... | San Jose-based Vocera Communications, which offers communications services for hospitals and health ... | mobihealth... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 29.03.2016 | Invitae expanding gene panels well beyond cancer | Genetic testing panels, more often than not, tend to focus these days on cancer. San Francisco’s Inv... | medcitynew... |
| 27.03.2015 | New digital health investment fund rises | In a phone interview with MedCity News, Kendall said the average size of investments it will make wi... | medcitynew... |
| 27.03.2015 | Genomics Needs A Killer App | Mark Kaganovich Contributor
Mark Kaganovich is the CEO and cofounder of SolveBio . Follow him on twi... | techcrunch... |
| 02.02.2015 | OrbiMed draws in more healthcare strategics in nearly $1 bil... | A dozen leading medical research and healthcare institutions contributed to the royalty and credit f... | medcitynew... |
| 17.01.2015 | The biggest healthtech deals of 2014 | Categories include telemedicine, digital medical devices and personalized medicine
This month, in an... | vator.tv/n... |
| 13.01.2015 | The future of next-gen sequencing (and why an Illumina cofou... | “It’s just that sequencing isn’t good enough today for many of the applications we’re looking at for... | medcitynew... |
| 09.01.2015 | Genetics testing company Invitae files for an initial public... | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 13.10.2014 | Invitae Completes $120M Series F Round |
SAN FRANCISCO, CA, Genetic information company, today announced the completion of a $120 million S... | vcnewsdail... |
| 13.10.2014 | Genetic information player Invitae raises $120M for global e... | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems stri... | medcitynew... |
| 13.10.2014 | Invitae raises $120M for its $1,500 gene sequencing test | Genomics will someday be your doctor’s major weapon for keeping you healthy throughout your life.
Th... | venturebea... |
| 13.10.2014 | Invitae Completed $120M Series F Financing | Invitae Corporation, a San Francisco, CA-based genetic information company, completed a $120m Series... | finsmes.co... |
| 13.10.2014 | Invitae raises $120M for its $1,500 gene sequencing test | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 11.12.2013 | Invitae Completes $40M Series E Financing | Invitae Corporation, a San Francisco, CA-based genetic diagnostics company, completed a $40m Series ... | finsmes.co... |
| 22.01.2013 | Genomics startup gets $3M to usher in new era of ‘personaliz... | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI an... | venturebea... |
| 22.01.2013 | Genomics startup gets $3M to usher in new era of ‘personaliz... | The cost of sequencing the human genome has plummeted. But how will this benefit doctors and patient... | venturebea... |
| 22.01.2013 | Syapse Raises $3M From The Social+Capital Partnership To Bri... | Founded at Stanford University in 2008, Syapse has been on a mission to help disrupt healthcare by i... | techcrunch... |
| - | Gene screenings hold disease clues, but unexplained anomalie... | When her gynecologist recommended genetic testing, Mai Tran was reluctant.
“I didn’t really want to ... | medcitynew... |
| - | Cathie Wood called this one of her most underappreciated sto... | Ark Invest’s Cathie Wood called Invitae one of her most underappreciated holdings.
The CEO of the ge... | cnbc.com/2... |
| - | OrbiMed draws in more healthcare strategics in nearly $1 bil... | Healthcare investor OrbiMed announced its second debt and royalty fund on Monday and continued to ex... | medcitynew... |
| - | The second coming of consumer genomics with 3 predictions fo... | As healthcare venture investors, my colleagues Adam Seabrook, Hailey Hu, and I identify disruptive t... | medcitynew... |
| - | Can telehealth solve America’s genetic counselor shortage? | Humans on average carry 1-2 mutations that could cause severe genetic disorders for them or their of... | medcitynew... |
| - | Genetic information player Invitae raises $120M for global e... | Gene diagnostics megaplayer Invitae has raised a whopping $120 million in a Series F round – proof p... | medcitynew... |
| - | Как американская компания Invitae построила корпоративную ку... | Как американская компания Invitae построила корпоративную культуру с тонким балансом свободы и ответ... | ain.ua/201... |
| - | The future of next-gen sequencing (and why an Illumina cofou... | John Stuelpnagel – one of Illumina‘s cofounders – has never had his genome sequenced.
“I didn’t feel... | medcitynew... |
| - | Charting the growth in the reproductive health genetic testi... | The reproductive genetic testing market is poised for substantial investment and growth as demand co... | medcitynew... |
| - | New digital health investment fund rises | In what feels like a counterweight to the ongoing discussion of the relatively few women partners in... | medcitynew... |
| - | A diagnostic odyssey: spotting the zebras among the horses | By Michele Cunningham
While individually rare, collectively there are more than 7,000 rare diseases ... | statnews.c... |
| - | Invitae to Present at the Oppenheimer 31st Annual Healthcare... | SAN FRANCISCO, March 4, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical gen... | oaoa.com/n... |
| - | Genetic insights can enhance hereditary cancer risk and care... | The multifactorial and heterogeneous nature of cancer makes it challenging to develop treatment plan... | statnews.c... |
| - | Invitae expanding gene panels well beyond cancer | Genetic testing panels, more often than not, tend to focus these days on cancer. San Francisco’s Inv... | medcitynew... |
| - | Invitae adds Medneon's risk assessment tools to its educatio... | SAN FRANCISCO, Feb. 24, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical gen... | oaoa.com/n... |
